Cargando…
Stem Cell Ophthalmology Treatment Study (SCOTS): improvement in serpiginous choroidopathy following autologous bone marrow derived stem cell treatment
We report results in a 77-year-old male patient with visual loss from long-standing serpiginous choroidopathy treated with bone marrow derived stem cells (BMSC) within the Stem Cell Ophthalmology Treatment Study (SCOTS). SCOTS is an Institutional Review Board approved clinical trial and the largest...
Autores principales: | Weiss, Jeffrey N., Benes, Susan C., Levy, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090858/ https://www.ncbi.nlm.nih.gov/pubmed/27857759 http://dx.doi.org/10.4103/1673-5374.191229 |
Ejemplares similares
-
Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber's hereditary optic neuropathy
por: Weiss, Jeffrey N., et al.
Publicado: (2016) -
Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Stargardt Disease
por: Weiss, Jeffrey N., et al.
Publicado: (2021) -
Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Age-Related Macular Degeneration
por: Weiss, Jeffrey N., et al.
Publicado: (2020) -
Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy
por: Weiss, Jeffrey N., et al.
Publicado: (2015) -
Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a preliminary report
por: Weiss, Jeffrey N., et al.
Publicado: (2015)